GB201401973D0 - Antibody polypeptides and uses thereof - Google Patents

Antibody polypeptides and uses thereof

Info

Publication number
GB201401973D0
GB201401973D0 GB201401973A GB201401973A GB201401973D0 GB 201401973 D0 GB201401973 D0 GB 201401973D0 GB 201401973 A GB201401973 A GB 201401973A GB 201401973 A GB201401973 A GB 201401973A GB 201401973 D0 GB201401973 D0 GB 201401973D0
Authority
GB
United Kingdom
Prior art keywords
antibody polypeptides
polypeptides
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201401973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FREDAX AB
Original Assignee
FREDAX AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FREDAX AB filed Critical FREDAX AB
Priority to GB201401973A priority Critical patent/GB201401973D0/en
Publication of GB201401973D0 publication Critical patent/GB201401973D0/en
Priority to CN201480072422.8A priority patent/CN105980404B/en
Priority to KR1020167016169A priority patent/KR102442738B1/en
Priority to DK14814696.2T priority patent/DK3071595T3/en
Priority to HUE14814696A priority patent/HUE043875T2/en
Priority to IL311788A priority patent/IL311788B1/en
Priority to SI201431143T priority patent/SI3071595T1/en
Priority to RU2016124229A priority patent/RU2687163C1/en
Priority to RS20190729A priority patent/RS58831B1/en
Priority to ES14814696T priority patent/ES2728515T3/en
Priority to MX2016006561A priority patent/MX383543B/en
Priority to AU2014351611A priority patent/AU2014351611B2/en
Priority to LTEP14814696.2T priority patent/LT3071595T/en
Priority to SM20190338T priority patent/SMT201900338T1/en
Priority to CN202011566401.5A priority patent/CN112898431B/en
Priority to JP2016532031A priority patent/JP6599859B2/en
Priority to BR112016011025-0A priority patent/BR112016011025B1/en
Priority to CA2930493A priority patent/CA2930493A1/en
Priority to EP14814696.2A priority patent/EP3071595B1/en
Priority to KR1020227003223A priority patent/KR102574537B1/en
Priority to KR1020237029468A priority patent/KR102894975B1/en
Priority to IL297678A priority patent/IL297678B2/en
Priority to PT14814696T priority patent/PT3071595T/en
Priority to HRP20191095TT priority patent/HRP20191095T1/en
Priority to EP19161698.6A priority patent/EP3553088B1/en
Priority to US15/036,170 priority patent/US10100125B2/en
Priority to PCT/GB2014/053420 priority patent/WO2015075445A1/en
Priority to PL14814696T priority patent/PL3071595T3/en
Priority to IL245617A priority patent/IL245617B/en
Priority to MX2021007006A priority patent/MX2021007006A/en
Priority to US16/117,522 priority patent/US11230609B2/en
Priority to CY20191100645T priority patent/CY1121900T1/en
Priority to JP2019181801A priority patent/JP7051777B2/en
Priority to AU2020207775A priority patent/AU2020207775B2/en
Priority to IL278493A priority patent/IL278493B2/en
Priority to US17/476,683 priority patent/US12404343B2/en
Priority to JP2022003634A priority patent/JP7592654B2/en
Priority to AU2023222879A priority patent/AU2023222879A1/en
Priority to JP2024201463A priority patent/JP2025019101A/en
Priority to IL323633A priority patent/IL323633A/en
Ceased legal-status Critical Current

Links

GB201401973A 2013-11-19 2014-02-05 Antibody polypeptides and uses thereof Ceased GB201401973D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GB201401973A GB201401973D0 (en) 2014-02-05 2014-02-05 Antibody polypeptides and uses thereof
PL14814696T PL3071595T3 (en) 2013-11-19 2014-11-19 HUMANIZED ANTIBODY AGAINST KALIKREIN-2
EP14814696.2A EP3071595B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
KR1020227003223A KR102574537B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
DK14814696.2T DK3071595T3 (en) 2013-11-19 2014-11-19 HUMANIZED ANTI-CALLICINE-2 ANTIBODY
HUE14814696A HUE043875T2 (en) 2013-11-19 2014-11-19 Humanized antibody to kallikrein-2
IL311788A IL311788B1 (en) 2013-11-19 2014-11-19 Humanized anti-kallikrein-2 antibody
SI201431143T SI3071595T1 (en) 2013-11-19 2014-11-19 Humanized kallikrein-2 antibody
RU2016124229A RU2687163C1 (en) 2013-11-19 2014-11-19 Antibodies polypeptides and use thereof
RS20190729A RS58831B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
ES14814696T ES2728515T3 (en) 2013-11-19 2014-11-19 Humanized anti-calicrein-2 antibody
MX2016006561A MX383543B (en) 2013-11-19 2014-11-19 HUMANIZED ANTI-KALLICREIN-2 ANTIBODY.
AU2014351611A AU2014351611B2 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
LTEP14814696.2T LT3071595T (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
SM20190338T SMT201900338T1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
CN202011566401.5A CN112898431B (en) 2013-11-19 2014-11-19 Humanized anti-kallikrein-2 antibody
KR1020167016169A KR102442738B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
BR112016011025-0A BR112016011025B1 (en) 2013-11-19 2014-11-19 ANTIBODY POLYPEPTIDES WITH BINDING SPECIFICITY FOR HUMAN KALYKREIN-2 (HK2), PHARMACEUTICAL COMPOSITION COMPRISING THEM AND NUCLEIC ACID MOLECULE
CA2930493A CA2930493A1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
CN201480072422.8A CN105980404B (en) 2013-11-19 2014-11-19 Humanized anti-kallikrein-2 antibodies
KR1020237029468A KR102894975B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
JP2016532031A JP6599859B2 (en) 2013-11-19 2014-11-19 Humanized anti-kallikrein-2 antibody
PCT/GB2014/053420 WO2015075445A1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
PT14814696T PT3071595T (en) 2013-11-19 2014-11-19 HUMANIZED ANTI-CALICREIN-2 ANTIBODY
HRP20191095TT HRP20191095T1 (en) 2013-11-19 2014-11-19 HUMANIZED ANTI-KALLIKREIN-2 ANTIBODY
EP19161698.6A EP3553088B1 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
US15/036,170 US10100125B2 (en) 2013-11-19 2014-11-19 Humanised anti kallikrein-2 antibody
IL297678A IL297678B2 (en) 2013-11-19 2014-11-19 Humanized antibody against kallikrein-2
IL245617A IL245617B (en) 2013-11-19 2016-05-11 Humanized antibody against kallikrein-2
MX2021007006A MX2021007006A (en) 2013-11-19 2016-05-19 Humanised anti kallikrein-2 antibody.
US16/117,522 US11230609B2 (en) 2013-11-19 2018-08-30 Humanised anti kallikrein-2 antibody
CY20191100645T CY1121900T1 (en) 2013-11-19 2019-06-20 HUMANIZED ANTI-KALLIKREIN-2 ANTIBODY
JP2019181801A JP7051777B2 (en) 2013-11-19 2019-10-02 Humanized anti-kallikrein-2 antibody
AU2020207775A AU2020207775B2 (en) 2013-11-19 2020-07-20 Humanised anti kallikrein-2 antibody
IL278493A IL278493B2 (en) 2013-11-19 2020-11-04 Humanised anti kallikrein-2 antibody
US17/476,683 US12404343B2 (en) 2013-11-19 2021-09-16 Humanised anti kallikrein-2 antibody
JP2022003634A JP7592654B2 (en) 2013-11-19 2022-01-13 Humanized anti-kallikrein-2 antibody
AU2023222879A AU2023222879A1 (en) 2013-11-19 2023-08-30 Humanised anti kallikrein-2 antibody
JP2024201463A JP2025019101A (en) 2013-11-19 2024-11-19 Humanized anti-kallikrein-2 antibody
IL323633A IL323633A (en) 2013-11-19 2025-09-28 Humanised anti kallikrein-2 antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201401973A GB201401973D0 (en) 2014-02-05 2014-02-05 Antibody polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
GB201401973D0 true GB201401973D0 (en) 2014-03-19

Family

ID=50344434

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201401973A Ceased GB201401973D0 (en) 2013-11-19 2014-02-05 Antibody polypeptides and uses thereof

Country Status (1)

Country Link
GB (1) GB201401973D0 (en)

Similar Documents

Publication Publication Date Title
IL275307B (en) Syntac polypeptides and uses thereof
IL258284A (en) Anti-lag3 antibodies and uses thereof
IL252804A0 (en) Anti-c10orf54 antibodies and uses thereof
IL257263A (en) Anti-angptl8 antibodies and uses thereof
IL251248A0 (en) Anti-interleukin-33 antibodies and uses thereof
IL254517B (en) Anti-muc16 antibodies and uses thereof
ZA201605894B (en) Anti-egfrviii antibodies and uses thereof
IL254955B (en) Anti-pacap antibodies and uses thereof
GB201403875D0 (en) Novel antibodies and uses thereof
GB201413913D0 (en) Novel antibodies and uses thereof
ZA201701663B (en) Anti-il-25 antibodies and uses thereof
IL247315A0 (en) Anti-acth antibodies and use thereof
GB201503387D0 (en) Anti-carbapenem antibodies and uses thereof
GB201410031D0 (en) Polypeptides and uses thereof
GB201401973D0 (en) Antibody polypeptides and uses thereof
GB201519105D0 (en) Antibody polypeptides and uses thereof
GB201517550D0 (en) Antibody polypeptides and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)